Gedea Biotech AB
Gedea Biotech develops an antibiotic-free, local treatment pHyph that both prevents and treats bacterial vaginosis (BV). The safety and effectiveness of the treatment has been confirmed in two phase 2 clinical studies in BV and the product is in European approval process.